Major China Biopharma Buys Bayer AG's Bay-Area Office/Lab Campus

Published: Dec 27, 2012

by Richard Daverman, PhD

December 27, 2012 -- A major, though as-yet unnamed, China biopharma has bought the prestigious San Francisco-area biotech campus that formerly belonged to Bayer. The six-building campus is located in Richmond, on the Berkeley side of the bay. The buyer has promised to disclose its identity and plans for the site next month. One source hints the company will seek to set up a biopharma hub, a US base for itself and other China biopharmas, rather than occupy the entire space itself. Whatever the plans turn out to be, the purchase signals a new phase in the relationship between US and China biopharmas. The purchase price was not disclosed. More details....

Stock Symbol: (Xetra: BAY)

Back to news